Nadolol in Pregnancy: A medical student’s reflection on her pregnancy
Hypertension is a common concern during pregnancy. Beta-blockers are one potential treatment, but third trimester exposure has correlated with an increased risk of perinatal events. Nadolol, a nonselective beta blocker, has properties that differ from those of its selective counterparts, including l...
Saved in:
Published in | Marshall journal of medicine Vol. 4; no. 4; pp. 1 - 21 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Marshall University
01.10.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Hypertension is a common concern during pregnancy. Beta-blockers are one potential treatment, but third trimester exposure has correlated with an increased risk of perinatal events. Nadolol, a nonselective beta blocker, has properties that differ from those of its selective counterparts, including longer half-life, decreased protein binding, and renal excretion in the unchanged form. There is very limited data on the use of nadolol during pregnancy, and its safety has not been completely evaluated. This case study documents the perinatal outcomes of nadolol use throughout a medical student’s pregnancy and explores the experience in obtaining and undergoing medical care. |
---|---|
ISSN: | 2379-9536 2379-9536 |
DOI: | 10.18590/mjm.2018.vol4.iss4.5 |